Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

XRAY DEADLINE FOR LEADERSHIP is January 27, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox

By: TheNewswire.com
<div><p>NEW YORK - (<a href="https://www.newmediawire.com">NewMediaWire</a>) - January 2, 2025 -&nbsp;<a href="https://www.kaplanfox.com/?utm_source=NMW&amp;utm_medium=Press+Release&amp;utm_campaign=Dentsply+Sirona&amp;utm_id=Dentsply+Sirona&amp;utm_term=XRAY+NMW">Kaplan Fox &amp; Kilsheimer LLP</a> announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. (&ldquo;DENTSPLY&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ: XRAY) on behalf of investors that purchased or otherwise acquired DENTSPLY securities between May 6, 2021 and November 6, 2024 (the &ldquo;Class Period&rdquo;).</p> <p><a href="https://www.kaplanfox.com/case/dentsply-sirona-inc/?utm_source=NMW&amp;utm_medium=Press+Release&amp;utm_campaign=Dentsply+Sirona&amp;utm_id=Dentsply+Sirona&amp;utm_term=XRAY+NMW">CLICK HERE TO JOIN THE CASE</a></p> <figure align="left" style="width: 240px; max-width: 100%; margin-bottom: 20px; float: left; margin-right: 20px;"><img src="http://newmediawire.s3.amazonaws.com/677339a6da846f3dd01a4a50_1" alt="" width="240" style="width: 240px; max-width: 100%; height: auto;" /></figure> <p><strong>If you are an investor in DENTSPLY and have suffered losses, you may </strong><a href="https://www.kaplanfox.com/case/dentsply-sirona-inc/?utm_source=NMW&amp;utm_medium=Press+Release&amp;utm_campaign=Dentsply+Sirona&amp;utm_id=Dentsply+Sirona&amp;utm_term=XRAY+NMW"><strong>CLICK HERE</strong></a><strong> to contact us. You may also contact Kaplan Fox by emailing </strong><a href="mailto:pmayer@kaplanfox.com"><strong>pmayer@kaplanfox.com</strong></a><strong> or by calling (646) 315-9003.</strong></p> <p><strong>DEADLINE REMINDER: </strong>If you are a member of the proposed Class, you may move the court <u><strong>no later than January 27, 2025</strong></u> to serve as a lead plaintiff for the purported class.&nbsp; If you have losses we encourage you to contact us to learn more about the lead plaintiff process.</p> <p>On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products."&nbsp; The press release also states that &ldquo;[t]he Company&rsquo;s decision was made in consultation with the U.S. Food and Drug Administration (FDA)."</p> <p>Following this news, the price of DENTSPLY's stock fell $1.10 per share, or 4.5%, to close at $23.31 per share on October 25, 2024.</p> <p>Then, on November 6, 2024, in connection with reporting third quarter financial results, DENTSPLY issued a press release revising its 2024 outlook to reflect that organic sales are expected to be down 3.5% to 2.5% year-over-year compared to its prior outlook that organic sales would be down 1% to flat.</p> <p>Following this news, the price of DENTSPLY&rsquo;s stock fell $6.72 per share, about 28%, to close at $17.26 per share on November 7, 2024.</p> <p><strong>WHY CONTACT KAPLAN FOX - </strong>Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.&nbsp; With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.&nbsp; Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.&nbsp; For more information about Kaplan Fox &amp; Kilsheimer LLP, you may visit our website at <a href="http://www.kaplanfox.com">www.kaplanfox.com</a>.</p> <p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.</p> <p>If you have any questions about this Notice, your rights, or your interests, please contact:</p> <p><strong>CONTACT:<br /></strong>Pamela A. Mayer<br /><a href="http://www.kaplanfox.com/">KAPLAN FOX &amp; KILSHEIMER LLP</a><br />800 Third Avenue, 38th Floor<br />New York, New York&nbsp;10022<br />(646) 315-9003<br /><a href="mailto:pmayer@kaplanfox.com">pmayer@kaplanfox.com</a></p> <p>Laurence D. King<br /><a href="http://www.kaplanfox.com/">KAPLAN FOX &amp; KILSHEIMER LLP</a><br />1999 Harrison Street, Suite 1560<br />Oakland, California 94612<br />(415) 772-4704<br /><a href="mailto:lking@kaplanfox.com">lking@kaplanfox.com</a></p><p class="nmw_link">View the original release on <a href="https://www.newmediawire.com/nmw_release/?rid=677339a6da846f3dd01a4a50/xray-deadline-for-leadership-is-january-27-2025-in-a-securities-fraud-lawsuit-contact-kaplan-fox">www.newmediawire.com</a></p></div>
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.